PeerCME is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerCME Publications, PeerCME is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peercme.com
Gesamtlänge aller Episoden: 3 days 38 minutes
Management of Lipid-Related Cardiovascular Risk: Emerging Data and Novel Therapeutic Options
Go online to www.peercme.com/h/pce3 to view the entire programme with slides.
Reducing Lipid-Related Cardiovascular Risk: Challenging Cases
Reducing Lipid-Related Cardiovascular Risk: Challenging Cases
Reducing Lipid-Related Cardiovascular Risk: Challenging Cases
Reducing Lipid-Related Cardiovascular Risk: Challenging Cases
Advances in Multiple Sclerosis: Evolving Roles of First-Line Injectable Options
Go online to www.peercme.com/h/pcr11 to view the entire programme with slides.
Advances in Multiple Sclerosis: Evolving Roles of First-Line Injectable Options
Go online to www.peercme.com/h/pcr11 to view the entire programme with slides.
Current and Future Roles of Targeting the Prostacyclin Pathway in Pulmonary Arterial Hypertension
Go online to www.peercme.com/h/pcr14 to view the entire programme with slides.
Current and Future Roles of Targeting the Prostacyclin Pathway in Pulmonary Arterial Hypertension
Go online to www.peercme.com/h/pcr14 to view the entire programme with slides.
Journal Club: Clinical Updates on Radionuclide-Based Therapy in Men With Castration-Resistant Prostate Cancer and Bone Metastases
Go online to www.peercme.com/h/pcj3 to view the entire programme with slides.
Journal Club: Clinical Updates on Radionuclide-Based Therapy in Men With Castration-Resistant Prostate Cancer and Bone Metastases
Go online to www.peercme.com/h/pcj3 to view the entire programme with slides.
Journal Club in Evolving Sequencing Strategies for Castration Resistant Prostate Cancer: Impact of Prior Docetaxel Use on Outcomes Associated With Radionuclide Therapy
Go online to www.peercme.com/h/pcj2 to view the entire programme with slides.